The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles

M Tauc, M Cougnon, R Carcy, N Melis, T Hauet… - Cell & Bioscience, 2021 - Springer
Since the demonstration of its involvement in cell proliferation, the eukaryotic initiation factor
5A (eIF5A) has been studied principally in relation to the development and progression of …

Emerging therapeutic targets for treatment of leishmaniasis

S Sundar, B Singh - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
Introduction: Parasitic diseases that pose a threat to human life include leishmaniasis–
caused by protozoan parasite Leishmania species. Existing drugs have limitations due to …

Arginase is essential for survival of Leishmania donovani promastigotes but not intracellular amastigotes

JM Boitz, CA Gilroy, TD Olenyik, D Paradis… - Infection and …, 2017 - Am Soc Microbiol
Studies of Leishmania donovani have shown that both ornithine decarboxylase and
spermidine synthase, two enzymes of the polyamine biosynthetic pathway, are critical for …

An Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage Invasion

A Goldman-Pinkovich, C Balno, R Strasser… - PLoS …, 2016 - journals.plos.org
Amino acid sensing is an intracellular function that supports nutrient homeostasis, largely
through controlled release of amino acids from lysosomal pools. The intracellular pathogen …

Natural Products That Target the Arginase in Leishmania Parasites Hold Therapeutic Promise

NS Carter, BD Stamper, F Elbarbry, V Nguyen, S Lopez… - Microorganisms, 2021 - mdpi.com
Parasites of the genus Leishmania cause a variety of devastating and often fatal diseases in
humans worldwide. Because a vaccine is not available and the currently small number of …

Polyamines in protozoan pathogens

MA Phillips - Journal of Biological Chemistry, 2018 - ASBMB
Polyamines are polycationic organic amines that are required for all eukaryotic life,
exemplified by the polyamine spermidine, which plays an essential role in translation. They …

Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis

N Goonoo, MA Laetitia Huët… - Royal Society …, 2022 - royalsocietypublishing.org
Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …

Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development

D Gupta, PK Singh, PK Yadav, T Narender… - International …, 2023 - Elsevier
Molecular therapy refers to targeted therapies based on molecules which have been
intelligently directed towards specific biomolecular structures and include small molecule …

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates

S Jain, U Sahu, A Kumar, P Khare - Pharmaceutics, 2022 - mdpi.com
Leishmaniasis is a tropical disease caused by a protozoan parasite Leishmania that is
transmitted via infected female sandflies. At present, leishmaniasis treatment mainly counts …

Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review

A Ilari, A Fiorillo, P Baiocco, E Poser… - Mini reviews in …, 2015 - ingentaconnect.com
Leishmaniasis is a neglected disease affecting more than 12 million people worldwide. The
most used drugs are pentavalent antimonials that are very toxic and display the problem of …